Feline Upper Respiratory Infections: Bacterial Pathogens and Diagnostic Approaches

Introduction

Feline upper respiratory infections (URI) represent a multifactorial disease complex in which viral and bacterial agents interact to produce clinical signs involving the nasal cavity, pharynx, larynx, and conjunctiva [1]. While viruses such as feline herpesvirus-1 (FHV-1) and feline calicivirus (FCV) are primary inciting agents, secondary or primary bacterial pathogens frequently exacerbate tissue damage and prolong disease [2]. Understanding the bacterial component of [cat bacterial respiratory infection] is essential for appropriate antimicrobial stewardship, accurate diagnosis, and effective outbreak management. This article reviews the major bacterial pathogens, their epidemiology, clinical presentation, diagnostic approaches, and control strategies within the context of feline medicine.

Primary Bacterial Pathogens

The most commonly isolated bacteria from cats with acute or chronic URI include Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma felis [1, 2]. Less frequently, Streptococcus equi subsp. zooepidemicus, Pasteurella multocida, Escherichia coli, and Klebsiella species are identified as opportunistic invaders [3]. Each pathogen exhibits distinct biological properties that influence diagnostic targeting and treatment.

Bordetella bronchiseptica

Bordetella bronchiseptica is a Gram-negative, aerobic coccobacillus that colonizes the ciliated respiratory epithelium of multiple mammalian hosts including cats, dogs, and pigs [1]. The bacterium expresses adhesins such as filamentous hemagglutinin and pertactin, as well as a bifunctional adenylate cyclase toxin that impairs phagocyte function [2]. In cats, B. bronchiseptica can act as a primary pathogen, particularly in overcrowded shelter environments, causing tracheobronchitis and rhinitis [3]. Transmission occurs via aerosol droplets and direct contact, with a carrier state established in recovered animals [1].

Chlamydia felis

Chlamydia felis is an obligate intracellular Gram-negative bacterium that targets conjunctival epithelial cells [2]. It is a leading cause of feline conjunctivitis, often presenting with chemosis, serous to mucopurulent ocular discharge, and blepharospasm [1, 2]. Nasal involvement is less common but can occur in co-infections. C. felis is zoonotically limited, with rare reports of conjunctivitis in immunocompromised humans [3].

Mycoplasma felis

Mycoplasma felis is a cell wall‑deficient, facultative intracellular bacterium that attaches to respiratory epithelial surfaces and red blood cells [2]. It is frequently isolated from the upper respiratory tract and conjunctiva of cats, especially in crowded settings [1]. Clinical signs include sneezing, nasal discharge, and conjunctivitis. M. felis is often a co‑pathogen with FHV‑1 or FCV [3].

Other Bacterial Species

Streptococcus equi subsp. zooepidemicus is a Gram‑positive coccus that can cause severe necrotizing tracheitis and pneumonia in cats, often with systemic dissemination [1]. Pasteurella multocida, a commensal of the feline oropharynx, may become pathogenic following mucosal damage [2]. Anaerobic bacteria such as Fusobacterium and Porphyromonas species contribute to chronic sinusitis and abscessation [3].

Epidemiology and Risk Factors

Bacterial URI in cats is strongly associated with high-density housing conditions: animal shelters, breeding catteries, and multi-cat households [1]. Risk factors include young age (less than 1 year), stress, poor ventilation, concurrent viral infection, and immunosuppression (e.g., feline immunodeficiency virus infection) [2]. The prevalence of B. bronchiseptica in shelter populations ranges from 10% to 50%, while C. felis approaches 20% in cats with conjunctivitis [3]. M. felis is found in up to 30% of cats with upper respiratory signs [1].

Clinical Signs and Pathology

Clinical presentation varies by pathogen load and host immune status. Common signs include sneezing, ocular and nasal discharge (serous, mucoid, or purulent), conjunctival hyperemia, chemosis, and submandibular lymphadenopathy [1]. B. bronchiseptica frequently induces a honking cough due to tracheal involvement [2]. C. felis typically triggers severe conjunctivitis with follicular hyperplasia [3]. S. zooepidemicus can cause acute onset dyspnea, cyanosis, and sudden death [1].

Pathologically, bacterial infection disrupts the mucociliary escalator, leading to epithelial erosion, submucosal edema, and neutrophilic infiltration [2]. Chronic infection may result in turbinate destruction, nasal polyp formation, and secondary bacterial rhinosinusitis [3].

Diagnostic Approaches

Accurate diagnosis of bacterial URI in cats requires integration of clinical examination, sample collection, and laboratory testing. The choice of diagnostic test depends on the suspected pathogen, available equipment, and turnaround time.

Sample Collection

For upper respiratory samples, sterile swabs (polyester or flocked) are used to collect secretions from the nasal cavity, nasopharynx, or conjunctival fornix [1]. Deep nasal flushing or bronchoalveolar lavage may be indicated for lower respiratory involvement [2]. Samples should be placed in appropriate transport media: Modified Stuart’s medium for bacterial culture, universal transport medium for PCR, and cytology fixative for microscopic evaluation [3].

Cytology

Microscopic examination of stained smears (Diff-Quik, Gram stain) provides immediate, low-cost information [1]. Presence of intracellular bacteria in neutrophils suggests Chlamydia (elementary bodies) or Mycoplasma [2]. Bordetella appears as small Gram‑negative coccobacilli, often extracellular [3].

Bacterial Culture and Antimicrobial Susceptibility Testing

Aerobic culture on blood agar and MacConkey agar is standard for isolating B. bronchiseptica, Pasteurella, enteric rods, and streptococci [1]. C. felis requires specialized cell culture and is rarely performed routinely [2]. Mycoplasma species require specific media (e.g., Mycoplasma broth) and prolonged incubation [3]. Antimicrobial susceptibility testing (disk diffusion or broth microdilution) guides therapy, especially given rising resistance rates in B. bronchiseptica and E. coli [1].

Molecular Diagnostics

Polymerase chain reaction (PCR) has become the gold standard for detecting fastidious or intracellular bacteria [2]. Real‑time PCR assays targeting species‑specific genes (e.g., flaA for B. bronchiseptica, 16S rRNA for Mycoplasma, ompA for C. felis) offer high sensitivity and specificity, often within hours [3]. Multiplex PCR panels that simultaneously detect FHV‑1, FCV, and bacterial pathogens are commercially available and increasingly used in practice. For detailed discussion, see the article on Point-of-Care Molecular Diagnostics for Feline Upper Respiratory Pathogens: FHV-1, FCV, and Bordetella.

Serology

Serological testing (e.g., ELISA for C. felis antibodies) has limited diagnostic utility in individual cats due to high seroprevalence in populations and cross‑reactivity [1]. It is primarily used for epidemiological studies.

Diagnostic Decision Making

The following mermaid diagram outlines a diagnostic workflow for cats presenting with acute URI.

graph TD
    A[Cat with upper respiratory signs], > B{Clinical exam}
    B, > C[Mild signs, no systemic disease]
    B, > D[Severe signs, chronic, or shelter outbreak]
    C, > E[Supportive care, monitor 3-5 days]
    D, > F[Collect samples: nasal/conjunctival swab]
    F, > G[Impression smear for cytology]
    G, > H{Evidence of intracellular bacteria?}
    H, >|Yes| I[PCR for Chlamydia / Mycoplasma]
    H, >|No| J[Aerobic culture + PCR panel]
    I, > K[Positive: targeted antimicrobial]
    I, > L[Negative: consider viral triggers]
    J, > M[Culture + susceptibility results]
    M, > N[Adjust antimicrobial therapy]
    N, > O[Recheck clinical response in 7 days]

Treatment and Antimicrobial Considerations

Empirical antimicrobial therapy is often initiated while awaiting diagnostic results in moderate to severe cases [1]. The choice of drug must target the most likely pathogens and preserve the feline microbiome. Table 1 summarizes recommended antimicrobials.

Table 1. Recommended Antimicrobials for Bacterial URI in Cats

Antimicrobial resistance is a growing concern. Methicillin‑resistant staphylococci and multi‑drug resistant E. coli have been isolated from feline URI cases, necessitating susceptibility testing [2]. Fluoroquinolones should be reserved for culture‑confirmed resistant infections due to risk of retinal toxicity in cats [3]. For an in‑depth review of antibiogram patterns, see Feline Upper Respiratory Tract Infections: Bacterial Etiology, Antibiograms, and Novel Therapeutics.

Control and Prevention

In multi‑cat environments, control relies on reducing stress, improving ventilation, and implementing cohort isolation [1]. Vaccination against B. bronchiseptica (intranasal) and C. felis (parenteral) is available but not universally recommended; it may be indicated in high‑risk shelters [2]. Routine cleaning with disinfectants effective against Gram‑negative bacteria and Chlamydia (e.g., accelerated hydrogen peroxide, bleach solution) is essential [3]. Recovered cats can remain carriers and should be segregated from naive populations. For public health considerations, see Feline Upper Respiratory Infections: Zoonotic Potential and Public Health.

Conclusion

Bacterial pathogens play a critical role in the pathogenesis and persistence of feline upper respiratory infections. A systematic diagnostic approach incorporating cytology, culture, and molecular testing allows targeted therapy and reduces unnecessary antimicrobial use. The emergence of resistant strains underscores the need for routine susceptibility testing and adherence to evidence‑based treatment protocols. Clinicians managing [cat bacterial respiratory infection] cases should integrate laboratory diagnostics with environmental management to optimize outcomes.

References

[1] Greene CE, Sykes JE. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis: Elsevier; 2012.

[2] Lappin MR. Feline Internal Medicine. 7th ed. St. Louis: Elsevier; 2020.

[3] Merck & Co. The Merck Veterinary Manual. 11th ed. Kenilworth: Merck Sharp & Dohme Corp.; 2016. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.